DANIEL LEE MOLLOY

DECATUR, GA

This page merges CMS profile IDs: 5705712, 6160330 (associated profiles published by CMS for the same provider; see the provenance section below).

General Payments — all program years on this page

$2,894.21

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 89
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $621.39 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $621.3921

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $42.692
2019 $431.509
2020 $727.9017
2021 $189.1310
2022 $356.6211
2023 $524.9819
2024 $621.3921

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087125488 Novartis Pharmaceuticals Corporation $16.24 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087125492 Novartis Pharmaceuticals Corporation $20.18 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087125494 Novartis Pharmaceuticals Corporation $21.71 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087125498 Novartis Pharmaceuticals Corporation $18.74 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087125500 Novartis Pharmaceuticals Corporation $14.31 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111654969 Amgen Inc. $18.13 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111654971 Amgen Inc. $17.40 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117141857 Medtronic, Inc. $20.79 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125857796 Alnylam Pharmaceuticals Inc. $27.02 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125857828 Alnylam Pharmaceuticals Inc. $20.33 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130965328 PFIZER INC. $14.18 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131004785 PFIZER INC. $16.79 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131774627 PFIZER INC. $16.19 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131852645 PFIZER INC. $16.86 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132115697 PFIZER INC. $16.86 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133237091 CVRx, Inc. $24.69 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142248084 ABIOMED $145.12 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142248196 ABIOMED $123.43 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154861375 Kiniksa Pharmaceuticals International, plc $14.03 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154861447 Kiniksa Pharmaceuticals International, plc $18.70 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154861461 Kiniksa Pharmaceuticals International, plc $19.69 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
  • Merged CMS profile IDs: 5705712, 6160330

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.